The CliniMACS Prodigy is an automated cell processing instrument designed for the efficient production of GMP-compliant cell and gene therapies. It addresses the manufacturing challenges of autologous and allogeneic therapies by simplifying workflows through automation and integration. With more than 300 custom workflows and use in more than 150 clinical trials, it has become the no. 1 platform for clinical and commercial cell manufacturing.

The CliniMACS Prodigy streamlines complex processes from cell washing, separation, genetic modification, and expansion to the formulated final cell product. Its versatility allows for standard or custom applications, making it ideal for a wide range of therapies, including T cell, NK cell, and stem cell treatments. Learn more about its full potential from clinical to commercial use.